Innocoll Initiates Clinical Trial To Investigate CollaRx For Prevention Of Surgical Site Infections

The first of two Innocoll’s phase 3 clinical trials to investigate CollaRx GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections, has commenced dosing.

This entry was posted on Friday, January 4th, 2008 at 10:10 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.